I
Ionis is a public biotech company commercializing RNA-targeted therapies, with five marketed medicines and a pipeline spanning neurology, cardiology, and other disease areas. The hiring mix is sales-heavy (33 roles) with significant research (15) and healthcare operations (11), reflecting a company in commercial-stage growth: they're actively launching wholly owned products and building patient access infrastructure while managing payer reimbursement barriers—a classic post-regulatory approval scaling challenge for specialty pharma.
Tech Stack 19 technologies
Core StackPython Smartsheet AWS Okta Databricks Power Platform Power Automate LC-MS R qPCR ChIP-seq RNA-seq Azure SQL Microsoft 365 SharePoint Teams OneDrive Excel
What Ionis Pharmaceuticals, Inc. Is Building
◆Challenges
- Access and reimbursement challenges
- Denial and appeals
- Patient access barriers
- Vendor compliance management
- Navigating access questions and challenges
- Payer policy barriers
- Payer policy navigation
- Payer coverage changes
- Reimbursement trends
- Optimal patient access
▲Active Projects
- Supply strategy development
- Strategic business plans for olezarsen and dawnzera
- Launch of ionis’s first wholly owned commercial product
- Metrics and reporting tools development
- Patient affordability programs
- Internal audit program
- Pipeline presentation to payers
- Vendor and system management
- Fic design cycle modeling
- Targeted rna-therapeutics delivery to immune cells
Hiring Activity
85 roles · 55 in 30d
Department
Seniority
Notable leadership hires: Medical Director, Associate Director, Field Incentive Compensation, Access Director, Compliance Monitoring Lead, Executive Director
Company intelligence
